Acute exacerbation of fibrosing interstitial lung disease
Conditions
Interventions
None listed
Sponsors
Wakayama Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cases treated for acute exacerbation of fibrosing interstitial lung disease between January 2012 and December 2019.
Exclusion criteria
Exclusion criteria: Cases in which the subject himself/herself has requested the refusal of the provision of information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To clarify the clinical course of fibrosing interstitial lung disease. | — |
Countries
Japan
Contacts
Public ContactKatsuyuki Furuta
Wakayama Medical University Department of Pulmonary Medicine and Medical Oncology
Outcome results
None listed